BioSig Technologies Plunges 9.28% Amid Merger Investigation

On May 27, 2025, BioSig Technologies experienced a significant drop of 9.28% in pre-market trading, sparking concerns among investors about the company's recent merger activities.

Halper Sadeh LLC, an investor rights law firm, has initiated an investigation into the fairness of the merger between BioSig Technologies, Inc. and Streamex Exchange. This investigation comes as a response to potential concerns from shareholders regarding the terms and conditions of the merger. The law firm is examining whether the merger is in the best interest of BioSig Technologies' shareholders, adding a layer of uncertainty to the company's future prospects.

The investigation by Halper Sadeh LLC has raised questions about the transparency and fairness of the merger process. Shareholders are closely monitoring the developments, as the outcome of the investigation could significantly impact the company's stock performance and strategic direction. The legal scrutiny adds to the existing challenges faced by BioSig Technologies, as it navigates through the complexities of the merger and its potential implications for the company's growth and stability.